Precisando de um Marcador Estrutural? (IMT) pode ajudar.

https://doi.org/10.1093/eurheartj/ehae533

Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction

.

IDF releases position statement recommending use of 1-hour plasma glucose test to diagnose intermediate hyperglycaemia and type 2 diabetes

There are many people who would not be diagnosed through an HbA1c or FPG test but who would, if given an OGTT, be more likely to be detected as having IH or T2D. The 1-h PG has been found to be a more sensitive biomarker for the earlier identification of these high-risk individuals